ACP3 and prostate adenocarcinoma: The antigen, PA2024, is a recombinant fusion protein involving prostatic acid phosphatase (PAP), which is expressed in the vast majority of prostate adenocarcinomas and is specific to prostate tissue, and granulocyte macrophage colony-stimulating factor (GM-CSF), a cytokine involved in immune cell maturation and activation.